Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

MALDI-TOF

CG Camille Le Gall
AC Anna Cammarata
LH Lukas de Haas
IR Iván Ramos-Tomillero
JC Jorge Cuenca-Escalona
KS Kayleigh Schouren
ZW Zacharias Wijfjes
AB Anouk M D Becker
JB Johanna Bödder
YD Yusuf Dölen
IV I Jolanda M de Vries
CF Carl G Figdor
GF Georgina Flórez-Grau
MV Martijn Verdoes
ask Ask a question
Favorite

(m/z) of the (GGG-K(N3)-FR-SLLMWITQ(Abu)) peptide before and after PEGylation was analyzed on Bruker Microflex LRF MALDI-TOF equipment. Samples were analyzed within a concentration range of 0.3–0.5 mg·mL-1 in ACN:ddH2O (1:1 v/v), using 1 µL of matrix-sample-matrix sown on the MALDI plate. Matrix: Sinapic acid (trans-3,5-dimethoxy-4-hydroxycinnamic acid) (D7927, Sigma Aldrich) at 10 mg·mL-1 in ACN:ddH2O (1:1 v/v) + 0.1% TFA.

Copyright and License information:  ©2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A